SCHEMBL6984052

SCHEMBL6984052

CCCCCCOC(=O)c1ccc(CCC(=O)N2CCCc3cc(NS(=O)(=O)c4ccccc4)ccc32)c(C(=N)N)c1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 6/20 0.48
ADRB1 P08588 6/20 0.48
ADRB3 P13945 6/20 0.48
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NR3C1 P04150 4/20 0.45
MAPT P10636 5/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
TP53 P04637 2/20 0.45
BRD4 O60885 1/20 0.41
CREBBP Q92793 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6978188 0.92 LMNA (0.54) ADRB2ADRB1ADRB3ALDH1A1LMNA
SCHEMBL6981264 0.90 NR3C1 (0.48) ADRB2ADRB1ADRB3ALDH1A1LMNA
SCHEMBL6985427 0.89 NR3C1 (0.49) ALDH1A1LMNAHPGDNPSR1NR3C1
SCHEMBL6984846 0.83 USP2 (0.38) ADRB2ADRB1ADRB3ALDH1A1LMNA
Hydrochloric Acid SCHEMBL7409665 0.82 NR3C1 (0.54) ADRB2ADRB1ADRB3LMNANR3C1
SCHEMBL6984049 0.82 NR3C1 (0.52) ADRB2ADRB1ADRB3ALDH1A1LMNA
SCHEMBL6981560 0.81 PDK1 (0.37) ADRB2ADRB1ADRB3ALDH1A1LMNA
SCHEMBL6976718 0.80 NR3C1 (0.42) ALDH1A1LMNAHPGDNPSR1NR3C1
SCHEMBL6982740 0.78 NR3C1 (0.59) LMNANR3C1MAPTSMN1; SMN2TP53
Hydrochloric Acid SCHEMBL6985312 0.78 NR3C1 (0.47) ADRB2ADRB1ADRB3ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed